JP2010521519A5 - - Google Patents

Download PDF

Info

Publication number
JP2010521519A5
JP2010521519A5 JP2009554033A JP2009554033A JP2010521519A5 JP 2010521519 A5 JP2010521519 A5 JP 2010521519A5 JP 2009554033 A JP2009554033 A JP 2009554033A JP 2009554033 A JP2009554033 A JP 2009554033A JP 2010521519 A5 JP2010521519 A5 JP 2010521519A5
Authority
JP
Japan
Prior art keywords
testosterone
boy
treatment
adolescent
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009554033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010521519A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/053372 external-priority patent/WO2008116825A2/en
Publication of JP2010521519A publication Critical patent/JP2010521519A/ja
Publication of JP2010521519A5 publication Critical patent/JP2010521519A5/ja
Pending legal-status Critical Current

Links

JP2009554033A 2007-03-23 2008-03-20 小児性腺機能低下症の治療用組成物及び治療方法 Pending JP2010521519A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07104726 2007-03-23
PCT/EP2008/053372 WO2008116825A2 (en) 2007-03-23 2008-03-20 Compositions and method for treating pediatric hypogonadism

Publications (2)

Publication Number Publication Date
JP2010521519A JP2010521519A (ja) 2010-06-24
JP2010521519A5 true JP2010521519A5 (th) 2011-05-06

Family

ID=38321980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009554033A Pending JP2010521519A (ja) 2007-03-23 2008-03-20 小児性腺機能低下症の治療用組成物及び治療方法

Country Status (10)

Country Link
EP (1) EP2136813A2 (th)
JP (1) JP2010521519A (th)
CN (1) CN101754764A (th)
AU (1) AU2008231781B2 (th)
BR (1) BRPI0809124A8 (th)
CA (1) CA2623477C (th)
EA (1) EA018775B1 (th)
IL (1) IL200887A0 (th)
MX (1) MX2009008995A (th)
WO (1) WO2008116825A2 (th)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
KR102088038B1 (ko) * 2011-05-15 2020-03-13 에이세러스 바이오파마 인크. 비내용 테스토스테론 겔의 조절된 방출, 경비성 투여를 위한 방법 및 미리-충전된 다회 용량 도포기 시스템

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
US7138389B2 (en) * 2004-02-09 2006-11-21 University Of Washington Oral androgen therapy using modulators of testosterone bioavailability
ZA200803087B (en) * 2005-10-12 2009-11-25 Unimed Pharmaceuticals Llc Improved testosterone gel and method of use

Similar Documents

Publication Publication Date Title
ATE511847T1 (de) Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes
RU2350333C3 (ru) Применение ивермектина для лечения дерматологических расстройств
WO2011053792A3 (en) Methods and compositions for sustained delivery of drugs
EP2671584A3 (en) Compositions and methods for treating disorders associated with salt or fluid retention
MX348705B (es) Composiciones farmacéuticas y métodos de administración relacionados.
NZ609719A (en) Pharmaceutical composition
EA201490876A1 (ru) Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей
BR0113663A (pt) Composições de pelìcula de pectina
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
JP2009522376A5 (th)
JP2013526620A5 (th)
EA201170117A1 (ru) Противоаллергические биополимеры морского происхождения
ES2720954T3 (es) Formulaciones estabilizadas de estatina
JP2011026348A5 (th)
HRP20211817T1 (hr) Postupak adjuvantnog liječenja raka
EP2251016A3 (en) Topical use of hyaluronic acid with folmogenic action for the treatment and prophylaxys of pathologies of the respiratory tract.
WO2009041111A1 (ja) 経口投与剤
BR112015019776A2 (pt) comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e métodos de uso dos comprimidos
DE602006016785D1 (de) Orale pharmazeutische zusammensetzung zur behandlung einer cox-2-vermittelten erkrankung
EP1905426A3 (en) Anti-acid pharmaceutical composition in powder form; pharmaceutical preparation containing it and process for making it
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
JP2010521519A5 (th)
RU2018125252A (ru) Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции
WO2007121545A8 (en) S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных